InnovHeart Achieves Milestone with First U.S. Saturn Transseptal TMVR Implanting 15 Patients Worldwide#USA#New_York#Saturn#InnovHeart#TMVR
InnovHeart Achieves Milestone with First U.S. Saturn Transseptal TMVR Implanting 15 Patients Worldwide
InnovHeart successfully implanted the first Saturn Transseptal TMVR System in the U.S., marking a pivotal moment for cardiac treatment as it expands globally.
third-news.com
September 3, 2026 at 3:38 PM
InnovHeart Achieves Milestone with First U.S. Saturn Transseptal TMVR Implanting 15 Patients Worldwide#USA#New_York#Saturn#InnovHeart#TMVR
Transseptal Access System Market Size, Growth, Trends 2035 www.marketresearchfuture.com/reports/tran...
Transseptal Access System Market Size, Share & Growth Report 2035 | MRFR
The Transseptal Access System market is projected to grow from USD Billion 1.533 in 2024 to USD Billion 3.334 by 2035, at a CAGR of 7.32% during 2025-2035.
www.marketresearchfuture.com
August 21, 2026 at 10:06 AM
Transseptal Access System Market Size, Growth, Trends 2035 www.marketresearchfuture.com/reports/tran...
Transseptal puncture for PFO with atrial septal aneurysm closure #REC https://www.revespcardiol.org/en-transseptal-puncture-for-pfo-with-atrial-articulo-S1885585725003251
August 19, 2026 at 6:00 PM
Transseptal puncture for PFO with atrial septal aneurysm closure #REC https://www.revespcardiol.org/en-transseptal-puncture-for-pfo-with-atrial-articulo-S1885585725003251
A single-session transfemoral TAVI and transfemoral/transseptal TMVR using dedicated devices was successfully performed in a patient with complex multivalvular disease. Discover more here:
eurointervention.pcronline.com/article/conc...
#cardiosky
eurointervention.pcronline.com/article/conc...
#cardiosky
July 17, 2026 at 1:07 PM
A single-session transfemoral TAVI and transfemoral/transseptal TMVR using dedicated devices was successfully performed in a patient with complex multivalvular disease. Discover more here:
eurointervention.pcronline.com/article/conc...
#cardiosky
eurointervention.pcronline.com/article/conc...
#cardiosky
Transseptal Needle Market Size, Growth Outlook 2035 www.marketresearchfuture.com/reports/tran...
Transseptal Needle Market Size, Growth Outlook 2035
Transseptal Needle Market growth is projected to reach USD 1.85 Billion, at a 7.32% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report 2025 to 20...
www.marketresearchfuture.com
July 17, 2026 at 6:06 AM
Transseptal Needle Market Size, Growth Outlook 2035 www.marketresearchfuture.com/reports/tran...
ElectroWire Medical Announces FDA Clearance for Innovative LightningWire Transseptal Puncture System#USA#FDA_Approval#Lexington#LightningWire#ElectroWire_Medical
ElectroWire Medical Announces FDA Clearance for Innovative LightningWire Transseptal Puncture System
ElectroWire Medical has received FDA 510(k) clearance for its LightningWire™, designed for transseptal puncture, enhancing procedures in cardiology.
third-news.com
July 15, 2026 at 4:12 PM
ElectroWire Medical Announces FDA Clearance for Innovative LightningWire Transseptal Puncture System#USA#FDA_Approval#Lexington#LightningWire#ElectroWire_Medical
Transseptal Access System Market Size, Growth, Trends 2035 www.marketresearchfuture.com/reports/tran...
Transseptal Access System Market Size, Growth, Trends 2035
Transseptal Access System Market growth is projected to reach 3.33 billion, at a 7.32% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report 2025 to...
www.marketresearchfuture.com
July 14, 2026 at 9:34 AM
Transseptal Access System Market Size, Growth, Trends 2035 www.marketresearchfuture.com/reports/tran...
New publication: Descending Aorta Perforation During Transseptal Puncture for Left Atrial Appendage Closure. Congratulations to the authors!
pubmed.ncbi.nlm.nih.gov/42177667/
#CVRCBern
pubmed.ncbi.nlm.nih.gov/42177667/
#CVRCBern
Descending Aorta Perforation During Transseptal Puncture for Left Atrial Appendage Closure - PubMed
Radiofrequency-powered systems for TSP have enhanced tissue penetration capability and should therefore be used with caution, particularly in the presence of an interatrial septum aneurysm and…
pubmed.ncbi.nlm.nih.gov
July 13, 2026 at 4:02 PM
New publication: Descending Aorta Perforation During Transseptal Puncture for Left Atrial Appendage Closure. Congratulations to the authors!
pubmed.ncbi.nlm.nih.gov/42177667/
#CVRCBern
pubmed.ncbi.nlm.nih.gov/42177667/
#CVRCBern
For patients with MAC and symptomatic MR who are typically not suitable for surgery or TEER, transseptal TMVR may be a promising option, with lower mortality rates and reduced MR based on data from the ENCIRCLE MAC registry. #NYValves2026 www.tctmd.com/news/transse...
Transseptal TMVR in MAC Shows Promise in Registry
Event rates, though relatively high, were lower than predicted, offering hope for patients with few options.
www.tctmd.com
July 3, 2026 at 1:50 PM
For patients with MAC and symptomatic MR who are typically not suitable for surgery or TEER, transseptal TMVR may be a promising option, with lower mortality rates and reduced MR based on data from the ENCIRCLE MAC registry. #NYValves2026 www.tctmd.com/news/transse...
It’s been an exciting second day at #NYValves2026! Watch Juan Granada and Nicolas Van Mieghem discuss the late-breaking transseptal TMVR in MAC, along with a new addition to CRF. www.tctmd.com/videos/ny-va...
June 25, 2026 at 10:36 PM
It’s been an exciting second day at #NYValves2026! Watch Juan Granada and Nicolas Van Mieghem discuss the late-breaking transseptal TMVR in MAC, along with a new addition to CRF. www.tctmd.com/videos/ny-va...
Transseptal TMVR in MAC Shows Promise in Registry
Transseptal TMVR in MAC Shows Promise in Registry
Transseptal TMVR in MAC Shows Promise in Registry
cmacahilig@crf.org
Thu, 06/25/2026 - 16:31
Yael L. Maxwell
Event rates, though relatively high, were lower than predicted, offering hope for patients with few options.
www.tctmd.com
June 25, 2026 at 8:40 PM
Transseptal TMVR in MAC Shows Promise in Registry
Transseptal Needle Market Size, Growth Outlook 2035 www.marketresearchfuture.com/reports/tran...
Transseptal Needle Market Size, Growth Outlook 2035
Transseptal Needle Market growth is projected to reach USD 1.85 Billion, at a 7.32% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report 2025 to 20...
www.marketresearchfuture.com
June 20, 2026 at 10:01 AM
Transseptal Needle Market Size, Growth Outlook 2035 www.marketresearchfuture.com/reports/tran...
The 8.5F VersaCross™ Steerable Sheath delivers controlled, high-precision steering for confident curve manipulation. Available as a standalone sheath or in a zero-exchange transseptal access solution with trusted VersaCross™ RF technology.
Learn more: qrco.de/bgqSEH
Learn more: qrco.de/bgqSEH
June 5, 2026 at 12:50 PM
The 8.5F VersaCross™ Steerable Sheath delivers controlled, high-precision steering for confident curve manipulation. Available as a standalone sheath or in a zero-exchange transseptal access solution with trusted VersaCross™ RF technology.
Learn more: qrco.de/bgqSEH
Learn more: qrco.de/bgqSEH
New registry data supports the efficacy and safety of transseptal BATMAN in high-risk TMVR patients with failed surgical valves, surgical rings, or severe mitral annular calcification (MAC) who are at increased risk of left ventricular outflow tract (LVOT) obstruction. www.tctmd.com/news/registr...
Registry Results Validate Transseptal BATMAN in High-risk TMVR Patients
The data reflect a high degree of technical success, clinical efficacy, and safety of the new technique, says Gennaro Giustino.
www.tctmd.com
May 30, 2026 at 1:09 PM
New registry data supports the efficacy and safety of transseptal BATMAN in high-risk TMVR patients with failed surgical valves, surgical rings, or severe mitral annular calcification (MAC) who are at increased risk of left ventricular outflow tract (LVOT) obstruction. www.tctmd.com/news/registr...
Early use of TMVR with the Sapien M3 device shows promising procedural and clinical outcomes, based on new European data presented at #EuroPCR 2026. www.tctmd.com/news/encoura...
Encouraging European Experience Seen With Transseptal TMVR
There are still some kinks to be ironed out, including risks of hemolysis and valve thrombosis, to put things on par with TEER.
www.tctmd.com
May 28, 2026 at 4:07 PM
Early use of TMVR with the Sapien M3 device shows promising procedural and clinical outcomes, based on new European data presented at #EuroPCR 2026. www.tctmd.com/news/encoura...
Transseptal Access System Market Size, Growth, Trends 2035 www.marketresearchfuture.com/reports/tran...
Transseptal Access System Market Size, Growth, Trends 2035
Transseptal Access System Market growth is projected to reach 3.33 billion, at a 7.32% CAGR by driving industry size, share, top company analysis, segments research, trends and forecast report 2025 to...
www.marketresearchfuture.com
May 20, 2026 at 8:45 AM
Transseptal Access System Market Size, Growth, Trends 2035 www.marketresearchfuture.com/reports/tran...
Giant left atrial appendage closure with the 40 mm watchman FLX pro: overcoming challenging anatomy and transseptal access🌟 by Romano et al. brings a fresh perspective to #CVImaging. Read it now in #IJCVI!
Giant left atrial appendage closure with the 40 mm watchman FLX pro: overcoming challenging anatomy and transseptal access
The International Journal of Cardiovascular Imaging - Percutaneous left atrial appendage (LAA) closure in giant anatomies remains a clinical challenge, especially when associated with suboptimal...
doi.org
April 27, 2026 at 7:53 PM
Giant left atrial appendage closure with the 40 mm watchman FLX pro: overcoming challenging anatomy and transseptal access🌟 by Romano et al. brings a fresh perspective to #CVImaging. Read it now in #IJCVI!
Protaryx Receives FDA Approval for Transseptal Puncture Device
Protaryx Receives FDA Approval for Transseptal Puncture Device
Protaryx Medical, a Maryland-based company dedicated to “minimally invasive left-heart interventional therapies,” announced that its Transseptal...
www.jdsupra.com
April 24, 2026 at 8:44 PM
Protaryx Receives FDA Approval for Transseptal Puncture Device
Protaryx Receives FDA Approval for Transseptal Puncture Device
Protaryx Receives FDA Approval for Transseptal Puncture Device
Protaryx Medical, a Maryland-based company dedicated to “minimally invasive left-heart interventional therapies,” announced that its Transseptal...
www.jdsupra.com
April 24, 2026 at 8:44 PM
Protaryx Receives FDA Approval for Transseptal Puncture Device
Protaryx Receives FDA Approval for Transseptal Puncture Device
Protaryx Receives FDA Approval for Transseptal Puncture Device
Protaryx Medical, a Maryland-based company dedicated to “minimally invasive left-heart interventional therapies,” announced that its Transseptal...
www.jdsupra.com
April 24, 2026 at 8:44 PM
Protaryx Receives FDA Approval for Transseptal Puncture Device
The 8.5F VersaCross™ Steerable Sheath is available as a standalone sheath or as part of an integrated zero-exchange transseptal access solution. Learn more: qrco.de/bgkvUL
VersaCross™ Steerable Access Solution indications, safety and warnings: qrco.de/bs-vst
VersaCross™ Steerable Access Solution indications, safety and warnings: qrco.de/bs-vst
April 23, 2026 at 12:45 PM
The 8.5F VersaCross™ Steerable Sheath is available as a standalone sheath or as part of an integrated zero-exchange transseptal access solution. Learn more: qrco.de/bgkvUL
VersaCross™ Steerable Access Solution indications, safety and warnings: qrco.de/bs-vst
VersaCross™ Steerable Access Solution indications, safety and warnings: qrco.de/bs-vst